Abstract:OBJECTIVE:To study the preparation of diagnostic gene chip for detecting hepatitis B virus (HBV) and hepatitis C virus (HCV) and its accuracy in detecting HBV DNA and HCV RNA in serum and liver tissues.METHODS:The probes, which depend on the conservative gene fragment of hepatitis virus, was designed, synthesized and spotted on the modified glass. The probes and some other control probes were assembled on the diagnostic microarray of hepatitis virus. The gene of hepatitis virus, purified from blood or tissue, was labeled with fluorescence and hybridized to the microarray. The hybridized microarry was scanned with microarray scanner and the diagnostic result was analyzed from the scanning data. Fourty patients with hepatitis B virus and 40 healthy people or 40 patients with hepatitis C virus were subjected to detection of HBV DNA and HCV RNA with the hepatitis virus gene chip by the double-blind method. Paraffin liver specimens obtained from 99 cases of posthepatitic cirrhosis were used to detect HBV DNA. The liver tissues and serum from 15 cases of chronic hepatitis B were used to detect HBV DNA. Simultaneously, HBsAg and HBcAg were detected in the serum by fluorescence microparticle quantitation, HBV DNA and HCV RNA in the serum by PCR, and HBcAg in liver tissues by immunocytochemistry or HBV DNA by in situ molecular hybridization.RESULTS:Chip detection of serum specimens showed that 30 patients were HBV DNA positive and 10 HBV DNA negative in the 40 patients with HBV positive, 25 patients were HCV RNA positive and 15 patients were HCV RNA negative in the 40 patients with HCV positive, and all were HBV and HCV negative in the 40 healthy people. In 15 patients with HBV marker positive who were subjected to liver biopsy, 15 patients were detected HBV DNA positive in serum by gene chip, 15 patients HBcAg positive in liver tissues by immunocytochemistry, 14 patients HBV DNA positive in liver tissues by in situ molecular hybridization, and 14 patients HBV DNA positive in liver tissues by gene chip. Paraffin liver tissues specimens from the 99 patients with posthepatitis B cirrhosis showed that 67 patients were detected HBcAg positive by immunocytochemistry, 53 patients HBV DNA positive by in situ molecular hybridization, and 46 patients HBV DNA positive by gene chip. In the 46 patients, 40 patients were detected HBV DNA and HBcAg positive by in situ molecular hybridization and immunocytochemistry, 6 patients only HBcAg positive, and 33 patients HBcAg negative.CONCLUSIONS:The designed diagnostic gene chip can be used to simultaneously detect serum HBV DNA and HCV RNA, but the positive rate of HCV RNA diagnosed by this chip is lower. The gene chip can detect HBV DNA in serum and in liver tissue.

Comparison of the Novel Real Time PCR Assay with Sequence Analysis , 27 Reverse Hybridization and Multiplex PCR for Hepatitis B Virus B and C 28 Genotyping

Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR

Quantitative Real-Time Pcr Analysis of Intestinal Regular Fungal Species in Fecal Samples from Patients with Chronic Hepatitis B Virus Infection

Analysis of Genotype and Quantification of Hepatitis B Virus by Real-Time PCR Assay

Evaluation of Two Type-Specific Primers PCR Genotyping Methods of Hepatitis B Virus

Study on hepatitis B virus genotypes in Wenzhou district by PCR using type-specific primers and its clinical significance

Hepatitis Gene Chip in Detecting HBV DNA, HCV RNA in Serum and Liver Tissue Samples of Hepatitis Patients.

Establishment and Application of a Type-Specific Polymerase Chain Reaction(pcr) for HBV Genotyping

Determination of Distribution of Hepatitis B Virus Genotype in Infected Population in Chongqing Region by Real-Time Fluorescent Genotyping and Quantitative PCR

Multiplex Locked Nucleic Acid Probes for Analysis of Hepatitis B Virus Mutants Using Real-Time PCR

Evaluation of a Novel Fully Automated Real-Time PCR Assay for Hepatitis B Virus DNA Quantification

Development of a Novel Genotype-Specific Loop-Mediated Isothermal Amplification Technique for Hepatitis B Virus Genotypes B and C Genotyping and Quantification

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

Establishment and application of a novel PCR assay for amplifying the full-length reverse transcriptase gene region of genotypes A～D of hepatitis B virus

To establish a new and simple method of genotyping of hepatitis B virus by PCR-RFLP to analysis on S region

Evaluation of clinical utility of a novel method for quantitative detection of hepatitis B virus RNA

[Establishment of a Nested PCR to Identify Hepatitis B Virus Genotypes A-D and Subgenotypes B1, B2, C1 and C2].

Establishment and Application of a Real-Time PCR Method to Detect Hepatitis B Virus Cccdna Quantitatively

Comparison of PCR-fluorescent-probe assay with DNA sequencing analysis for the detection of Hepatitis B virus YMDD mutation

ELISA genotyping of hepatitis B virus in China with antibodies specific for genotypes B and C

A Type-Specific Nested PCR Assay Established and Applied for Investigation of HBV Genotype and Subgenotype in Chinese Patients with Chronic HBV Infection.